- FBRX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Forte Biosciences (FBRX) 8-K2 Sep 21Clinical Trial of FB-401 for the Treatment of Atopic Dermatitis Fails to Meet Statistical SignificanceFinancial data
Company Profile